Regulatory and scientific virtual conference on RNA-based medicines

EventHumanResearch and developmentSME

Date: Thursday, 02 February 2023, 09:00 (CET) - 16:30 (CET)
Location: Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

The aim of the conference is to promote the development of RNA-based medicines by:

Identifying scientific and regulatory opportunities and challenges of RNA-based innovative medicines;
Facilitating dialogue between industry/academia and regulators and raising awareness on scientific and regulatory aspects;
Identifying gaps in regulatory science.

This initiative addresses Goal 1 (catalysing the integration of science and technology in medicines development) of the EMA Regulatory Science Strategy to 2025.

The conference focuses on emerging RNA technologies beyond vaccines.

RNA for gene editing and primary prevention of infectious diseases is not within the scope of this event.

Video recording

Documents

Report - Regulatory and scientific virtual conference on RNA-based medicines

English (EN) (320.12 KB - PDF)

First published: 24/02/2023

Agenda - Regulatory and scientific virtual conference on RNA-based medicines

English (EN) (523.98 KB - PDF)

First published: 09/12/2022Last updated: 09/02/2023

Speakers’ biography

English (EN) (569.94 KB - PDF)

First published: 08/02/2023

Presentation - State of the Art of RNA Technologies_EU regulators’ perspective (Sol Ruiz)

English (EN) (11.79 MB - PDF)

First published: 08/02/2023

Presentation - A brief introduction into oligonucleotide therapies (Annemieke Aartsma-Rus)

English (EN) (923.16 KB - PDF)

First published: 08/02/2023

Presentation - State of the Art of RNA Technologies "Industry Perspective" (Tal Zaks)

English (EN) (1.36 MB - PDF)

First published: 08/02/2023

Presentation - EU Regulators’ experience with synthetic oligonucleotides and mRNA technology (René Thürmer)

English (EN) (993.92 KB - PDF)

First published: 08/02/2023

Presentation - Industry perspective on synthetic oligonucleotide (Daniel Capaldi)

English (EN) (1.18 MB - PDF)

First published: 08/02/2023

Presentation - Industry perspective on mRNA technology (Pawel Widomski)

English (EN) (9.86 MB - PDF)

First published: 08/02/2023

Presentation - Opportunities and challenges in non-clinical development - Academic Perspective (Haiyan Zhou)

English (EN) (1.42 MB - PDF)

First published: 08/02/2023

Presentation - Application of RNA Technologies Non-Clinical Industry perspective (Susan Goody)

English (EN) (921.99 KB - PDF)

First published: 08/02/2023

Presentation - Opportunities and challenges in non-clinical development - The regulator's perspective (Camilla Svensson)

English (EN) (681.23 KB - PDF)

First published: 08/02/2023

Presentation - Applications of RNA technologies - Clinical_Academia perspective (David Henshall)

English (EN) (2.49 MB - PDF)

First published: 08/02/2023

Presentation - Applications of RNA technologies - Clinical - An Industry Perspective (Michael Wenger)

English (EN) (478.6 KB - PDF)

First published: 08/02/2023

Presentation - Applications of RNA technologies - Clinical - Regulators' perspective (Joop van Gerven)

English (EN) (314.86 KB - PDF)

First published: 08/02/2023